Literature DB >> 22133091

Ameliorative effect of methanol extract of Rubia cordifolia in N-nitrosodiethylamine-induced hepatocellular carcinoma.

P N Shilpa1, Sivaramakrishnan Venkatabalasubramanian, Sivasitambaram Niranjali Devaraj.   

Abstract

CONTEXT: Rubia cordifolia Linn. (Rubiaceae) is a medicinal plant used in the ayurvedic system of medicine. It is also known as Indian Madder or Manjistha and is traditionally used as an antiinflammatory, antiseptic, and galactopurifier, but its anticancer propertis are yet not known.
OBJECTIVE: The ameliorative effect of the Rubia cordifolia methanol extract on N-nitrosodiethylamine-induced experimental hepatocellular carcinogenesis in rats.
MATERIALS AND METHODS: Changes in liver weight, serum markers of liver damage, hydroxyl radicals, lipid peroxidation, levels of enzymic and nonenzymic antioxidants; mitochondrial and respiratory chain enzymes were also investigated using various biochemical parameters and histopathological studies. Male albino rats of Wistar strain were divided into four groups for a study period of 3 months. Animals of group I and group IV served as control and drug control, respectively. Hepatocellular carcinoma was induced in animals of groups II and III with 0.02% N-nitrosodiethylamine.
RESULTS: Upon Rubia cordifolia methanol extract co-treatment (250, 500, and 750 mg/kg bodyweight) in group III alone levels of serum marker enzymes and antioxidants increased significantly in a dose-dependent manner. The levels of hydroxyl radicals and lipid peroxidation decreased. Mitochondrial enzymes and respiratory chain enzymes, which were decreased in N-nitrosodiethylamine-induced rats, increased significantly in RC treated rats. Further histological analysis of liver confirmed the prevention of pathological changes caused by N-nitrosodiethylamine on Rubia cordifolia supplementation. DISCUSSION AND
CONCLUSION: These findings demonstrate that Rubia cordifolia can be a source of potent antioxidants for treatment of diseases such as cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133091     DOI: 10.3109/13880209.2011.608073

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  8 in total

1.  FFJ-3 inhibits PKM2 protein expression via the PI3K/Akt signaling pathway and activates the mitochondrial apoptosis signaling pathway in human cancer cells.

Authors:  Dengyun Li; Xiaoli Wei; Mingming Ma; Huina Jia; Yu Zhang; Wenyi Kang; Tianxiao Wang; Xiaoyan Shi
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

2.  Induction of apoptosis by FFJ-5, a novel naphthoquinone compound, occurs via downregulation of PKM2 in A549 and HepG2 cells.

Authors:  Xiaoli Wei; Ming Li; Mingming Ma; Huina Jia; Yu Zhang; Wenyi Kang; Tianxiao Wang; Xiaoyan Shi
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

3.  TMARg, a Novel Anthraquinone Isolated from Rubia cordifolia Nakai, Increases Osteogenesis and Mineralization through BMP2 and β-Catenin Signaling.

Authors:  Kyung-Ran Park; Joon Yeop Lee; Bo-Mi Kim; Sang Wook Kang; Hyung-Mun Yun
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

4.  Crosstalk of Cancer Signaling Pathways by Cyclic Hexapeptides and Anthraquinones from Rubia cordifolia.

Authors:  Premalatha Balachandran; Mohamed Ali Ibrahim; Jin Zhang; Mei Wang; David S Pasco; Ilias Muhammad
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

5.  Antioxidant and Polyphenol-Rich Ethanolic Extract of Rubia tinctorum L. Prevents Urolithiasis in an Ethylene Glycol Experimental Model in Rats.

Authors:  Fatima Zahra Marhoume; Rachida Aboufatima; Younes Zaid; Youness Limami; Raphaël E Duval; Jawad Laadraoui; Anass Belbachir; Abderrahmane Chait; Abdallah Bagri
Journal:  Molecules       Date:  2021-02-14       Impact factor: 4.411

6.  ZnO Nanoparticles of Rubia cordifolia Extract Formulation Developed and Optimized with QbD Application, Considering Ex Vivo Skin Permeation, Antimicrobial and Antioxidant Properties.

Authors:  Jasmeet Kaur; Md Khalid Anwer; Ali Sartaj; Bibhu Prasad Panda; Abuzer Ali; Ameeduzzafar Zafar; Vinay Kumar; Sadaf Jamal Gilani; Chandra Kala; Mohamad Taleuzzaman
Journal:  Molecules       Date:  2022-02-21       Impact factor: 4.411

7.  Rubia cordifolia L. ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of NLRP3 inflammasome and IL-6/JAK2/STAT3 pathways.

Authors:  Wei Qin; Han Luo; Liu Yang; Di Hu; Su-Ping Jiang; Dai-Yin Peng; Jiang-Miao Hu; Shou-Jin Liu
Journal:  Heliyon       Date:  2022-08-19

Review 8.  A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications.

Authors:  Min Wen; Qi Chen; Wang Chen; Jing Yang; Xiaogang Zhou; Chunxiang Zhang; Anguo Wu; Jia Lai; Jianping Chen; Qibing Mei; Shuo Yang; Cai Lan; Jianming Wu; Feihong Huang; Long Wang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.